BioCentury
ARTICLE | Company News

Vivus, Mist Pharmaceuticals deal

October 10, 2016 7:00 AM UTC

Vivus granted Mist’s Metuchen Pharmaceuticals LLC affiliate exclusive rights to commercialize erectile dysfunction drug Stendra avanafil in the U.S., Canada, South America and India. Vivus will recei...